Minque, Baby Boy .
HRN: 24-32-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2024
OXACILLIN 500MG (VIAL)
02/14/2024
02/16/2024
IVT
55mg
Q8hrd
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes